Equine liver review underscores metabolism’s clinical importance: full analysis

Version 2

A review in The Veterinary Clinics of North America: Equine Practice puts the equine liver back in focus as one of the body’s most consequential multitaskers, emphasizing that its importance goes far beyond detoxification alone. In “Liver Metabolism and Function,” Michelle Henry Barton outlines the liver’s central role in metabolizing carbohydrates, proteins, and lipids, converting nutrients for storage or export, and processing both internal metabolic byproducts and external compounds. That framing matters because it helps explain why hepatic disease in horses can show up as a nutrition problem, a neurologic problem, a performance problem, or all three at once. (eu.elsevierhealth.com)

The broader literature has long described the liver as essential to homeostasis, but current reference sources continue to stress how many systems depend on intact hepatic function. Merck’s veterinary references describe the liver as central to synthesis, metabolism, bioactivation, conjugation, elimination, vitamin handling, mineral storage, and production of proteins involved in coagulation and acute-phase responses. In horses specifically, the organ’s functional reserve and regenerative capacity can mask disease until injury is advanced, which is one reason equine hepatic disorders may be underrecognized early in the course of illness. (merckvetmanual.com)

That background helps place Barton’s review in context. The article appears in an equine-focused issue devoted to the liver, suggesting a practical aim: reconnecting physiology with clinical decision-making. Supporting sources note that the liver regulates blood glucose, converts ammonia to urea, contributes to bile formation and excretion, and metabolizes drugs, toxins, hormones, and lipids. When those functions begin to fail, veterinarians may see combinations of icterus, weight loss, altered mentation, photosensitization, hypoproteinemia, coagulopathy, or poor tolerance of metabolic stress, depending on whether disease is acute, chronic, inflammatory, toxic, infectious, or metabolic in origin. (merckvetmanual.com)

Although direct outside commentary on this specific review was limited, the surrounding expert literature points in the same direction. Sharon Center’s Merck overview emphasizes that hepatic function spans synthetic, metabolic, and immunologic roles, while equine-focused references note that routine serum enzyme testing is sensitive for detecting hepatocellular or cholestatic injury but does not, by itself, measure true functional reserve. That distinction is especially important in horses, where fasting-related bilirubin changes, chronic fibrosis, or evolving hepatic encephalopathy can complicate interpretation if clinicians rely too heavily on a narrow lab snapshot. (merckvetmanual.com)

Nutrition is another major thread. Equine nutrition guidance for sick horses notes that in hepatic disease, clinicians are often trying to provide enough protein and energy while reducing metabolic waste burdens and preserving gut function. Older equine liver disease reviews likewise emphasize nutritional management, particularly in metabolic disorders such as hyperlipemia. In practice, that means liver cases often require coordinated decisions on forage, caloric density, protein quality, feeding frequency, and monitoring, rather than a simple “rest and recheck” plan. (merckvetmanual.com)

Why it matters: For veterinary teams, the value of a review like this is less about novelty than integration. It reinforces that liver disease can influence nearly every step of case management, from interpreting chemistry panels and selecting confirmatory tests to planning sedation, drug dosing, hospitalization, and nutrition support. It also supports a more cautious conversation with pet parents: a horse with liver involvement may still have meaningful regenerative potential, but prognosis changes substantially once fibrosis, hepatic failure, or severe neurologic signs emerge. (merckvetmanual.com)

The article also lands at a time when equine clinicians are balancing increasingly detailed diagnostics with practical field realities. Because liver enzyme abnormalities do not always equal loss of function, and because clinical signs may be subtle early on, reviews that tie metabolism to bedside recognition can help practitioners decide when to escalate to bile acids, ammonia measurement, ultrasound, or biopsy. That’s especially relevant in referral settings, internal medicine workups, and chronic poor-doer cases where hepatic disease may not be the first differential raised. (merckvetmanual.com)

What to watch: The next step is likely continued emphasis on earlier functional assessment, more tailored nutritional support, and sharper differentiation between hepatic injury and hepatic insufficiency in horses, particularly as clinicians apply these principles to chronic weight loss, hyperlipemia risk, and encephalopathic presentations. (merckvetmanual.com)